Characteristics of patients diagnosed with AIDS shortly after first detection of HIV antibodies in Lyon University hospitals from 1985 to 2001

HIV Medicine

Volumn 5, Issue 4, 2004, Pages 273-277

  Baratin, D ^a   Marceillac, E ^a   Trepo, C ^b   Cotte, L ^b   Peyramond, D ^c   Chidiac, C ^c   Touraine, J L ^a   Livrozet, J M ^a   Fabry, J ^a   Allard, R ^d   Vanhems, Philippe ^a,e  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b HÔTEL DIEU   (France)

^c CROIX ROUSSE HOSPITAL   (France)

^d MCGILL UNIVERSITY   (Canada)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; GROUPS BY AGE; HEALTH CARE ACCESS; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MULTIPLE REGRESSION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGE FACTORS; AIDS SERODIAGNOSIS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; HETEROSEXUALITY; HIV-1; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PNEUMONIA, PNEUMOCYSTIS; RISK FACTORS; SEX FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 4043149986     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2004.00220.x     Document Type: Article

References (17)

1. Girardi E, Sampaolesi A, Gentile M et al. Increasing proportion of late diagnosis of HIV infection among patients with AIDS in Italy following introduction of combination antiretroviral therapy. J Acquir Immune Defic Syndr 2000; 25: 71-76.
2. Porter K, Wall PG, Evans BG. Factors associated with lack of awareness of HIV infection before diagnosis of AIDS. Br Med J 1993; 307: 20-23.
3. Vernay-Vaisse C, Enel P, Bendiane MK, Rey D, Carrieri MP, Obadia Y. Facteurs associés à la découverte de la séropositivité à un stade d'immunodépression avancé. Bull Epidemiol 2002; 15: 61-63.
4. Katz MH, Bindman AB, Komaromy MS. Coping with HIV infection: why people delay care. Ann Intern Med 1992; 117: 797.
5. Couturier E, Schwoebel V, Michon C et al. Determinants of delayed diagnosis of HIV infection in France, 1993-95. AIDS 1998; 12: 795-800.
6. Vanhems P, Baratin D, Allard R et al. Factors associated with the time elapsed between the initial detection of HIV-1 antibodies and a diagnosis of AIDS among patients followed in Lyons University hospitals. Sex Transm Infect 1999; 75: 389-391.
7. Palella FJ Jr, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-860.
8. European Centre for the Epidemiological Monitoring of AIDS 1993 Revision of the European AIDS Surveillance Case Definition. AIDS Surveillance in Europe, Quarterly Report. Saint-Maurice, France, European Centre for the Epidemiological Monitoring of AIDS, 1993 [N37:23-28].
9. Poznansky MC, Coker R, Skinner C et al. HIV positive patients first presenting with AIDS defining illness: characteristics and survival. Br Med J 1995; 311: 156-158.
10. Catchpole MA, McGarrigle CA, Rogers PA, Jordan LF, Mercey DE, Gill NO. Serosurveillance of prevalence of undiagnosed HIV-1 infection in homosexual men with acute sexually transmitted infection. Br Med J 2000; 321: 1319-1320.
11. Samet JH, Freedberg KA, Savetsky JB, Sullivan LM, Stein MD. Understanding delay to medical care for HIV infection: the long-term non-presenter. AIDS 2001; 15: 77-85.
12. Mallal SA, Martinez OP, French MA, James IR, Dawkins RL. Severity and outcome of Pneumocystis carinii pneumonia (PCP) in patients of known and unknown HIV status. J Acquir Immune Defic Syndr 1994; 7: 148-153.
13. Catchpole MA, Mercey DE, Nicoll A et al. on behalf of the Collaborative Group. Continuing transmission of sexually transmitted diseases among patients infected with HIV-1 attending genitourinary medicine clinics in England and Wales. Br Med J 1996; 312: 539-542.
14. 3. Multicenter AIDS Cohort Study. J Infect Dis 1994; 170: 1284-1287.
15. Phillips AN, Staszewski S, Weber R et al. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. J Am Med Assoc 2001; 286: 2560-2567.
16. Delfraissy JF. Prise en charge des personnel infectéees par le VIH, rapport 2002. Médecine-Sciences Flammarion: 37-38.
17. Hogg RS, Yip B, Chan KJ et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. J Am Med Assoc 2001; 286: 2568-2577.